Using Sheep to Study Human Tumors and Radioimmunotherapy
Author Information
Author(s): JH Turner, AH Rose, RJ Glancy, WJ Penhale
Primary Institution: University of Western Australia
Hypothesis
Can a large animal model of human tumors in immunosuppressed sheep provide more accurate predictions for clinical efficacy of radioimmunotherapy compared to nude mouse models?
Conclusion
The study found that tumor uptake of radiolabelled monoclonal antibodies in sheep is comparable to that observed in patients, suggesting this model may better predict clinical outcomes than traditional mouse models.
Supporting Evidence
- Sheep demonstrated tumor uptake of targeted radiolabelled monoclonal antibodies comparable to clinical trials.
- Immunosuppression in sheep was achieved without significant adverse effects.
- Multiple tumor types were successfully xenografted in sheep, allowing for diverse studies.
Takeaway
Researchers used sheep to grow human tumors and found that the way the tumors absorbed treatment was similar to how humans do, which could help in testing new cancer therapies.
Methodology
Human tumor cells were transplanted into immunosuppressed sheep, and the uptake of radiolabelled monoclonal antibodies was measured over time.
Limitations
The study duration was relatively short, and the model may not fully replicate human tumor behavior over longer periods.
Participant Demographics
Twelve-week-old Merino/dorset-cross sheep weighing approximately 25 kg.
Want to read the original?
Access the complete publication on the publisher's website